Literature DB >> 17915852

Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs.

Claudia Binda1, Jin Wang, Leonardo Pisani, Carla Caccia, Angelo Carotti, Patricia Salvati, Dale E Edmondson, Andrea Mattevi.   

Abstract

Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivatives, all sharing a common benzyloxy substituent, were determined by X-ray crystallography. These compounds competitively inhibit MAO B with Ki values in the 0.1-0.5 microM range that are 30-700-fold lower than those observed with MAO A. The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17915852     DOI: 10.1021/jm070677y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  89 in total

Review 1.  Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects.

Authors:  Anthony H V Schapira
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

Review 2.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

3.  Interactions of monoamine oxidases with the antiepileptic drug zonisamide: specificity of inhibition and structure of the human monoamine oxidase B complex.

Authors:  Claudia Binda; Milagros Aldeco; Andrea Mattevi; Dale E Edmondson
Journal:  J Med Chem       Date:  2010-12-22       Impact factor: 7.446

4.  Coumarin-benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation.

Authors:  L Ravithej Singh; Srinivasa Rao Avula; Sneha Raj; Akanksha Srivastava; Gopala Reddy Palnati; C K M Tripathi; Mukesh Pasupuleti; Koneni V Sashidhara
Journal:  J Antibiot (Tokyo)       Date:  2017-06-21       Impact factor: 2.649

5.  Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs.

Authors:  Claudia Binda; Milagros Aldeco; Werner J Geldenhuys; Marcello Tortorici; Andrea Mattevi; Dale E Edmondson
Journal:  ACS Med Chem Lett       Date:  2011-10-15       Impact factor: 4.345

Review 6.  Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases.

Authors:  Dale E Edmondson; Claudia Binda; Jin Wang; Anup K Upadhyay; Andrea Mattevi
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

7.  Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B.

Authors:  Pankaj Pandey; Narayan D Chaurasiya; Babu L Tekwani; Robert J Doerksen
Journal:  Biochem Pharmacol       Date:  2018-06-26       Impact factor: 5.858

8.  Synthesis, molecular modeling, and in vitro screening of monoamine oxidase inhibitory activities of some novel hydrazone derivatives.

Authors:  Umut Salgin-Gökşen; Nesrin Gökhan-Kelekçi; Samiye Yabanoglu-Çiftci; Kemal Yelekçi; Gülberk Uçar
Journal:  J Neural Transm (Vienna)       Date:  2013-01-18       Impact factor: 3.575

Review 9.  Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.

Authors:  Thomas Müller; Paul Foley
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447

10.  In silico identification of novel and selective monoamine oxidase B inhibitors.

Authors:  Kemal Yelekçi; Bora Büyüktürk; Nurdan Kayrak
Journal:  J Neural Transm (Vienna)       Date:  2012-12-15       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.